Quantification of Residual Water in Pharmaceutical Frozen Solutions via

(1)H NMR Dupixent Solid-state NMR biologics freeze concentrate freeze-drying frozen solution phase change residual water

Journal

Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R

Informations de publication

Date de publication:
19 Apr 2024
Historique:
received: 26 10 2023
revised: 11 04 2024
accepted: 11 04 2024
medline: 22 4 2024
pubmed: 22 4 2024
entrez: 21 4 2024
Statut: aheadofprint

Résumé

Freezing is essential for the stability of biological drug substances and products, particularly in frozen solution formulations and during the primary drying of lyophilized preparations. However, the unfrozen segment within the frozen matrix can alter solute concentration, ionic strength, and stabilizer crystallization, posing risks of increased biophysical instability and faster chemical degradation. While quantifying the unfrozen water content is important for designing stable biopharmaceuticals, there is a lack of analytical techniques for in situ quantitative measurements. In this study, we introduce a

Identifiants

pubmed: 38643897
pii: S0022-3549(24)00144-8
doi: 10.1016/j.xphs.2024.04.013
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Yong Du (Y)

Analytical Research and Development, Merck & Co. Inc., Rahway, NJ 07065, USA.

Yongchao Su (Y)

Analytical Research and Development, Merck & Co. Inc., Rahway, NJ 07065, USA; Pharmaceutical Sciences and Clinical Supply, Merck & Co. Inc., West Point, PA 19486, USA. Electronic address: yongchao.su@merck.com.

Classifications MeSH